Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CERS stock hub

Cerus Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CERSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

523M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CERS

In the news

Latest news · CERS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-15.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-1.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CERS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001020214
Company name	Cerus Corporation
Country	United States
Country code	US
Cusip	157085101
Employees	275
Employees Change	1%
Employees Change Percent	0.36
Enterprise value	$539.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	1997-01-30
Isin	US1570851014
Last refreshed	2026-05-10
Market cap	$523M
Market cap category	Small-Cap
Price	$2.61
Price currency	USD
Rev Per Employee	787,472.73x
Sector	Healthcare
Sic	3841
Symbol	CERS
Website	https://www.cerus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.83%
EV Sales Forward	2.08x
EV/Sales	2.49x
FCF yield	-0.23%
P/B ratio	7.74x
P/S ratio	2.41x
PS Forward	2.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.47%
EBITDA Margin	-0.75%
Gross margin	52.99%
Gross Profit	$114.8M
Gross Profit Growth	10.69%
Gross Profit Growth Q	9.72%
Gross Profit Growth3 Y	10.52%
Gross Profit Growth5 Y	16.82%
Net Income	$-9.6M
Net Income Growth Quarters	5%
Net Income Growth Years	6%
Pretax Margin	-4.25%
Profit Margin	-4.41%
Profit Per Employee	$-34,727
ROA	-0.93
Roa5y	-7.5
ROCE	-2.75
ROE	-15.37
Roe5y	-47.67
ROIC	-1.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.2%
Cagr15y	-0.25%
Cagr1y	100.87%
Cagr20y	-4.93%
Cagr3y	4.61%
Cagr5y	-15.71%
EPS Growth Quarters	1
EPS Growth Years	6
OCF Growth	-69.24%
Revenue Growth	16.97x
Revenue Growth Q	24.1x
Revenue Growth Quarters	12x
Revenue Growth Years	2x
Revenue Growth3 Y	11.65x
Revenue Growth5 Y	17.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.01
Assets	$222.9M
Cash	$80.4M
Current Assets	$175.3M
Current Liabilities	$107.4M
Debt	$97.4M
Debt EBITDA	$38.39
Debt Equity	$1.43
Equity	$68.3M
Interest Coverage	-0.39
Liabilities	$154.6M
Long Term Assets	$47.6M
Long Term Liabilities	$47.2M
Net Cash	$-16.9M
Net Cash By Market Cap	$-3.24
Net Debt Equity	$0.25
Tangible Book Value	$66.2M
Tangible Book Value Per Share	$0.33
WACC	12.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.63
Inventory Turnover	1.86
Net Working Capital	$43.1M
Quick ratio	1.02
Working Capital	$68M
Working Capital Turnover	$2.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.63%
1Y total return	100.77%
200-day SMA	1.82
3Y total return	14.47%
50-day SMA	2.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-57.46%
All Time High	81.88
All Time High Change	-96.81%
All Time High Date	2000-12-29
All Time Low	0.55
All Time Low Change	374.55%
All Time Low Date	2008-12-17
ATR	0.19
Beta	1.62
Beta1y	1.44
Beta2y	1.77
Ch YTD	26.7
High	2.66
High52	3.15
High52 Date	2026-05-01
High52ch	-17.14%
Low	2.48
Low52	1.15
Low52 Date	2025-08-21
Low52ch	126.96%
Ma50ch	29.85%
Premarket Change Percent	0.77
Premarket Price	$2.63
Premarket Volume	3,273
Price vs 200-day SMA	43.49%
RSI	71.13
RSI Monthly	57.27
RSI Weekly	61.86
Sharpe ratio	1.23x
Sortino ratio	2.24
Total Return	-3.53%
Tr YTD	26.7
Tr15y	-3.69%
Tr1m	41.85%
Tr1w	-4.04%
Tr3m	18.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.03
Earnings Revenue Estimate	51,177,670x
Earnings Revenue Estimate Growth	18.36x
Operating Income	$-3.2M
Operating margin	-1.47
Price target	$4
Price Target Change	$53.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,113,665%
Float Percent	95.88%
Net Borrowing	-201,000
Shares Insiders	4.11%
Shares Institutions	73.35%
Shares Out	200,368,974
Shares Qo Q	1.06%
Shares Yo Y	3.53%
Short Float	5.83%
Short Ratio	8.09
Short Shares	5.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-22.4M
Average Volume	2,738,132.2x
Bv Per Share	0.34
CAPEX	$-3.9M
Ch10y	-52.63
Ch15y	-3.69
Ch1m	41.85
Ch1w	-4.04
Ch1y	100.8
Ch20y	-63.6
Ch3m	18.64
Ch3y	14.47
Ch5y	-57.46
Ch6m	52.63
Change	0%
Change From Open	0
Close	2.61
Days Gap	0
Depreciation Amortization	1,566,000
Dollar Volume	5,745,599.2
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$-3.2M
EBITDA	$-1.6M
EPS	$-0.05
F Score	4
FCF	$-1.2M
FCF EV Yield	-0.23x
FCF Per Share	$-0.01
Financing CF	352,000
Fiscal Year End	December
Founded	1,991
Goodwill	1,316,000
Income Tax	$371,000
Investing CF	4,884,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	1.98
Ma150ch	31.62%
Ma20	2.18
Ma20ch	19.78%
Net CF	7,896,000
Next Earnings Date	2026-08-04
Open	2.61
Optionable	Yes
P OCF Ratio	198.7
Position In Range	72.22
Post Close	2.61
Postmarket Change Percent	-3.45
Postmarket Price	$2.52
Ppne	18,698,000
Pre Close	2.61
Price Date	2026-05-08
Ptbv Ratio	7.9
Relative Volume	0.8x
Revenue	216,555,000x
SBC By Revenue	9.76x
Share Based Comp	21,136,000
Tax By Revenue	0.17x
Tr20y	-63.6%
Tr6m	52.63%
Us State	California
Volume	2,201,379
Z Score	-4.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CERS pay a dividend?

Capital-return profile for this ticker.

Performance

CERS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CERS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+73.4%

Float: +95.9% of shares outstanding

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CERS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.1

Above 70: short-term overbought

Price vs 200-day MA

+43.5%

50/200-day relationship not available

Beta (5Y)

1.62

More volatile than the market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CERS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CERS stock rating?

Cerus Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CERS analysis?

The full report lives at /stocks/CERS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CERS?

The latest report frames CERS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CERS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.